COMMUNIQUÉS West-GlobeNewswire

Demant A/S: Interim Report 2019
14/08/2019
Company announcement no 2019-07 14 August 2019 Interim Report 2019 8% growth for the Group – recent product launches drive growth acceleration into H2 12% unit growth drives market share gains in hearing aid wholesale [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
13/08/2019
Company Release no. 13/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 August 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial Results
13/08/2019
Strong Quarter-Over-Quarter Performance 26% Increase in U.S. Product Revenue 46% Increase in Dermatology Revenue 23% Reduction in Operating Expenses PETALUMA, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Sonoma [...]
Synergy CHC Corp. Announces Second Quarter 2019 Results
13/08/2019
Westbrook, Maine, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30th, [...]
KemPharm Reports Second Quarter 2019 Results
13/08/2019
CELEBRATION, Fla., Aug. 13, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and [...]
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
13/08/2019
Phase Ib study of DM199 in Chronic Kidney Disease enrollment complete Encouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II CKD protocol submitted, [...]
Novan Takes Steps to Reduce Real Estate Footprint
13/08/2019
Company entered into negotiations with third party to transfer lease obligation Non-binding letter of intent signed 60-day exclusivity period to finalize details A successful transaction would lead to a reduction in [...]
Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results
13/08/2019
CHARLESTON, S.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the second quarter ended June 30, 2019. All Amounts are in U.S [...]
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
13/08/2019
Conference Call & Webcast Scheduled for Wednesday, August 14, at 8:30am Eastern Time GAITHERSBURG, Md., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, [...]
Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
13/08/2019
SAN DIEGO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
13/08/2019
NEWTON, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Cyclacel Pharmaceuticals Reports Second Quarter 2019 Financial Results
13/08/2019
- Conference Call Scheduled August 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Silk Road Medical Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
13/08/2019
SUNNYVALE, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing [...]
CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update
13/08/2019
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and [...]
Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
13/08/2019
SEATTLE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended June 30, 2019. “At Adaptive, we are [...]
electroCore Announces Second Quarter 2019 Financial Results
13/08/2019
Sequential growth reported in paid months of therapy, prescribing physicians and prescriptions dispensed Company to host conference call and webcast today, August 13, at 4:30pm ET BASKING RIDGE, N.J., Aug. 13, 2019 ( [...]
Shlomo Yanai Resigns as Chairman of the Board of Protalix BioTherapeutics
13/08/2019
CARMIEL, Israel, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX) today announced that Shlomo Yanai has resigned from the Company’s Board of Directors for personal reasons [...]
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
13/08/2019
REDWOOD CITY, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, [...]
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results
13/08/2019
Total Fourth-Quarter Revenues of $215.4 Million Fourth-Quarter Diluted EPS of ($0.06) and Adjusted EPS of $0.41 SALT LAKE CITY, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “ [...]

Pages